KR20130139895A - 경도인지 장애의 치료 또는 예방용 융합 트리아졸 - Google Patents

경도인지 장애의 치료 또는 예방용 융합 트리아졸 Download PDF

Info

Publication number
KR20130139895A
KR20130139895A KR1020137008170A KR20137008170A KR20130139895A KR 20130139895 A KR20130139895 A KR 20130139895A KR 1020137008170 A KR1020137008170 A KR 1020137008170A KR 20137008170 A KR20137008170 A KR 20137008170A KR 20130139895 A KR20130139895 A KR 20130139895A
Authority
KR
South Korea
Prior art keywords
optionally substituted
compound
group
ring
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020137008170A
Other languages
English (en)
Korean (ko)
Inventor
다츠키 고이케
미노루 나카무라
요시히데 도마타
다카후미 다카이
야스타카 호아시
유이치 가지타
데츠야 츠카모토
마코토 가마타
Original Assignee
다케다 야쿠힌 고교 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45094181&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20130139895(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 다케다 야쿠힌 고교 가부시키가이샤 filed Critical 다케다 야쿠힌 고교 가부시키가이샤
Publication of KR20130139895A publication Critical patent/KR20130139895A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020137008170A 2010-09-02 2011-09-01 경도인지 장애의 치료 또는 예방용 융합 트리아졸 Withdrawn KR20130139895A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JPJP-P-2010-197064 2010-09-02
JP2010197064 2010-09-02
JP2011143548 2011-06-28
JPJP-P-2011-143548 2011-06-28
PCT/JP2011/070419 WO2012029991A1 (en) 2010-09-02 2011-09-01 Fused triazoles for the treatment or prophylaxis of mild cognitive impairment

Publications (1)

Publication Number Publication Date
KR20130139895A true KR20130139895A (ko) 2013-12-23

Family

ID=45094181

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137008170A Withdrawn KR20130139895A (ko) 2010-09-02 2011-09-01 경도인지 장애의 치료 또는 예방용 융합 트리아졸

Country Status (22)

Country Link
US (3) US8822699B2 (cg-RX-API-DMAC7.html)
EP (1) EP2611805A1 (cg-RX-API-DMAC7.html)
JP (1) JP5871909B2 (cg-RX-API-DMAC7.html)
KR (1) KR20130139895A (cg-RX-API-DMAC7.html)
CN (1) CN103249733A (cg-RX-API-DMAC7.html)
AR (1) AR082865A1 (cg-RX-API-DMAC7.html)
AU (1) AU2011296887A1 (cg-RX-API-DMAC7.html)
BR (1) BR112013004746A2 (cg-RX-API-DMAC7.html)
CA (1) CA2809779A1 (cg-RX-API-DMAC7.html)
CL (1) CL2013000575A1 (cg-RX-API-DMAC7.html)
DO (1) DOP2013000051A (cg-RX-API-DMAC7.html)
EA (1) EA201390333A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP13012535A (cg-RX-API-DMAC7.html)
MA (1) MA34556B1 (cg-RX-API-DMAC7.html)
MX (1) MX2013002511A (cg-RX-API-DMAC7.html)
PE (1) PE20131305A1 (cg-RX-API-DMAC7.html)
PH (1) PH12013500403A1 (cg-RX-API-DMAC7.html)
SG (1) SG187917A1 (cg-RX-API-DMAC7.html)
TW (1) TW201213327A (cg-RX-API-DMAC7.html)
UY (1) UY33586A (cg-RX-API-DMAC7.html)
WO (1) WO2012029991A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201301929B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120142672A1 (en) * 2009-07-13 2012-06-07 Tatsuki Koike Heterocyclic compound and use thereof
UY33586A (es) * 2010-09-02 2012-03-30 Takeda Pharmaceutical Compuesto heterocíclico y sus usos
EP2687528A1 (en) * 2012-07-17 2014-01-22 Ares Trading S.A. Fused triazole derivatives as gamma secretase modulators
RU2563254C2 (ru) * 2013-07-08 2015-09-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Способ получения производных 7-(гетеро)арил-4,5,6,7-тетрагидро[1,2,3]триазоло[1,5-a]пиридина
RU2750293C2 (ru) * 2015-05-12 2021-06-25 ЭфЭмСи Корпорейшн Арилзамещенные бициклические соединения в качестве гербицидов
MY202326A (en) * 2017-09-14 2024-04-24 Daiichi Sankyo Co Ltd Compound having cyclic structure
US20210079182A1 (en) * 2019-09-12 2021-03-18 Dupont Electronics, Inc. Polyimide films and electronic devices
IL313039A (en) * 2021-12-17 2024-07-01 Athira Pharma Inc Uses of bicyclic compounds for the treatment of diseases
CN118047687A (zh) * 2024-01-29 2024-05-17 湖州澄博生物科技有限公司 一种用于对20(s)喜树碱结构进行修饰的化合物及其合成方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1261610A2 (en) 2000-02-17 2002-12-04 Bristol-Myers Squibb Pharma Company Succinoylamino carbocycles and heterocycles as inhibitors of a-beta protein production
CN102584813B (zh) 2003-05-14 2016-07-06 Ngc药物公司 化合物及其在调节淀粉样蛋白β中的用途
CA2539811A1 (en) * 2003-10-15 2005-04-28 Targacept, Inc. Azabicycyclic compounds for relieving pain and treating central nervous system disorders
EP2261218B1 (en) 2004-05-26 2013-04-03 Eisai R&D Management Co., Ltd. Imidazole compound for use as an intermediate in the production of cinnamide compounds
KR20070083781A (ko) 2004-10-26 2007-08-24 에자이 알앤드디 매니지먼트 가부시키가이샤 신나미드 화합물의 비정질체
JP2009523170A (ja) 2006-01-11 2009-06-18 メルク エンド カムパニー インコーポレーテッド 縮合トリアゾールタキキニン受容体アンダニスト
TWI378091B (en) 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
GEP20115139B (en) 2006-03-09 2011-01-10 Eisai R&D Man Co Ltd Polycyclic cinnamide derivative
TW200808800A (en) 2006-05-05 2008-02-16 Astrazeneca Ab MGluR5 modulators V
TW200835502A (en) 2006-12-26 2008-09-01 Daiichi Sankyo Co Ltd Thiazepine derivatives
US8143394B2 (en) 2006-12-26 2012-03-27 Gilead Sciences, Inc. Pyrido(3,2-d)pyrimidines useful for treating viral infections
WO2008097538A1 (en) 2007-02-08 2008-08-14 Merck & Co., Inc. Therapeutic agents
MX2010006243A (es) 2007-12-06 2010-08-31 Schering Corp Moduladores de gamma secretasa.
TW201030002A (en) * 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2010197064A (ja) 2009-02-23 2010-09-09 Chugoku Electric Power Co Inc:The 直下位置測定装置
JP2012051806A (ja) * 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
RU2515976C2 (ru) 2009-02-26 2014-05-20 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Азотсодержащие конденсированные гетероциклические соединения и их применение в качестве ингибиторов продукции бета-амилоида
JP2012051807A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd アリールイミダゾール化合物
WO2011002067A1 (ja) 2009-07-02 2011-01-06 武田薬品工業株式会社 複素環化合物およびその用途
US20120142672A1 (en) * 2009-07-13 2012-06-07 Tatsuki Koike Heterocyclic compound and use thereof
WO2011006903A1 (en) 2009-07-15 2011-01-20 Ortho-Mcneil-Janssen Pharmaceuticals, Inc Substituted triazole and imidazole derivatives as gamma secretase modulators
US8637525B2 (en) 2009-07-31 2014-01-28 Bristol-Myers Squibb Company Compounds for the reduction of beta-amyloid production
TWI468402B (zh) 2009-07-31 2015-01-11 必治妥美雅史谷比公司 降低β-類澱粉生成之化合物
WO2011016559A1 (ja) 2009-08-07 2011-02-10 武田薬品工業株式会社 複素環化合物およびその用途
JP2011143548A (ja) 2010-01-12 2011-07-28 Panasonic Corp スクリーン印刷機及びスクリーン印刷方法
PH12012501381A1 (en) 2010-01-15 2012-10-22 Janssen Pharmaceuticals Inc Novel substituted bicyclic triazole derivatives as gamma secretase modulators
UY33586A (es) * 2010-09-02 2012-03-30 Takeda Pharmaceutical Compuesto heterocíclico y sus usos

Also Published As

Publication number Publication date
CN103249733A (zh) 2013-08-14
MX2013002511A (es) 2013-07-29
PE20131305A1 (es) 2013-10-31
WO2012029991A1 (en) 2012-03-08
SG187917A1 (en) 2013-04-30
CA2809779A1 (en) 2012-03-08
UY33586A (es) 2012-03-30
CL2013000575A1 (es) 2013-08-23
EP2611805A1 (en) 2013-07-10
EA201390333A1 (ru) 2013-08-30
US20130178497A1 (en) 2013-07-11
AU2011296887A1 (en) 2013-04-11
ECSP13012535A (es) 2013-06-28
AR082865A1 (es) 2013-01-16
US8822699B2 (en) 2014-09-02
US20120059030A1 (en) 2012-03-08
JP5871909B2 (ja) 2016-03-01
DOP2013000051A (es) 2013-04-30
TW201213327A (en) 2012-04-01
PH12013500403A1 (en) 2013-03-25
JP2013536798A (ja) 2013-09-26
MA34556B1 (fr) 2013-09-02
US20140350260A1 (en) 2014-11-27
BR112013004746A2 (pt) 2016-06-07
US8901309B2 (en) 2014-12-02
ZA201301929B (en) 2013-11-27

Similar Documents

Publication Publication Date Title
JP5871909B2 (ja) 複素環化合物及びその用途
DK2763979T3 (en) 1-arylcarbonyl-4-oxy-piperidine compounds for the treatment of neurodegenerative diseases
ES2695350T3 (es) Compuesto heterocíclico
CN114144230B (zh) 作为eed和prc2调节剂的大环唑并吡啶衍生物
AU2013253516B2 (en) Nitrogenated heterocyclic compound
JPWO2014030743A1 (ja) 複素環化合物
JP2017510564A (ja) 新規なヘテロ芳香族誘導体およびそれらの医薬としての使用
WO2011002067A1 (ja) 複素環化合物およびその用途
TW202229248A (zh) Hsd17b13抑制劑及其用途
UA129557C2 (uk) Похідні діоксолоізохінолінону та їх застосування
WO2011145735A1 (ja) チアゾール誘導体
JP5888702B2 (ja) 抗癌活性化合物
KR20260022448A (ko) 디히드로피리미딘-2,4(1h,3h)-디온을 함유하는 폴리시클릭 유도체 및 이의 약학적 조성물, 이의 제조 방법 및 이의 용도
WO2012008508A1 (ja) 複素環化合物
WO2013005354A1 (ja) 複素環化合物
JP2012136500A (ja) 複素環化合物
EP4046688B1 (en) Heterocyclic compound
WO2026029204A1 (en) Compounds as sort1 inhibitors
WO2013100018A1 (ja) 複素環化合物
HK1196368A (en) 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
HK1196368B (en) 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PC1203 Withdrawal of no request for examination

St.27 status event code: N-1-6-B10-B12-nap-PC1203

WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid
R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000